Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance.
Francesca Di MarioAlice SabatinoGiuseppe RegolistiMaria Chiara PacchiariniPaolo GrecoCaterina MaccariGiuseppe VizziniChiara ItalianoValentina PistolesiSanto MorabitoEnrico FiaccadoriPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2023)
Our data obtained with a new simplified RCA protocol suggest that it is effective and safe for CVVH, CVVHDF and SLED, allowing to prevent KRT-related hypophosphatemia and maintain the acid-base balance without citrate accumulation. Trial registration: NCT03976440 registered June 6, 2019.